Skip to main content
. 2016 Sep 7;2016:7648215. doi: 10.1155/2016/7648215

Figure 2.

Figure 2

The relationship between serum level of miR-663 and 5-year overall and relapse-free survival rates of nasopharyngeal carcinoma patients.